About outset medical inc - OM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
OM At a Glance
Outset Medical, Inc.
3052 Orchard Drive
San Jose, California 95134
| Phone | 1-669-231-8200 | Revenue | 119.48M | |
| Industry | Medical Specialties | Net Income | -81,653,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 5.09% | |
| Fiscal Year-end | 12 / 2026 | Employees | 310 | |
| View SEC Filings |
OM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.472 |
| Price to Book Ratio | 0.531 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.181 |
| Enterprise Value to Sales | -0.094 |
| Total Debt to Enterprise Value | -8.987 |
OM Efficiency
| Revenue/Employee | 385,406.452 |
| Income Per Employee | -263,396.774 |
| Receivables Turnover | 4.217 |
| Total Asset Turnover | 0.442 |
OM Liquidity
| Current Ratio | 6.667 |
| Quick Ratio | 5.402 |
| Cash Ratio | 4.49 |
OM Profitability
| Gross Margin | 39.133 |
| Operating Margin | -55.839 |
| Pretax Margin | -67.742 |
| Net Margin | -68.343 |
| Return on Assets | -30.226 |
| Return on Equity | -106.201 |
| Return on Total Capital | -35.781 |
| Return on Invested Capital | -36.023 |
OM Capital Structure
| Total Debt to Total Equity | 79.752 |
| Total Debt to Total Capital | 44.368 |
| Total Debt to Total Assets | 38.279 |
| Long-Term Debt to Equity | 78.382 |
| Long-Term Debt to Total Capital | 43.606 |